Literature DB >> 12916953

Diffusion of a freely water-soluble drug in aqueous enteric-coated pellets.

H X Guo1, J Heinämäki, J Yliruusi.   

Abstract

The effects of filler used in the pellet cores (ie, waxy cornstarch or lactose) and the enteric film coat thickness on the diffusion and dissolution of a freely soluble drug were studied. Two kinds of pellet cores containing riboflavin sodium phosphate as a model drug, microcrystalline cellulose (MCC) as a basic filler, and waxy cornstarch or lactose as a cofiller were film coated (theoretically weight increase 20% or 30%) with an aqueous dispersion of cellulose acetate phthalate (CAP). The diffusion of riboflavin sodium phosphate in aqueous enteric-coated pellets was investigated using noninvasive confocal laser scanning microscopy (CLSM). The in vitro release tests were performed using a USP apparatus I (basket method). Diffusion of drug from the core to the film coat was found to be greater with lactose-containing pellets than with waxy cornstarch-containing pellets. The dissolution test showed that 30% enteric-coated waxy cornstarch pellets had a good acidic resistance in 0.1 N HCl solution for at least 1 hour, while the other enteric pellet formulations failed the test. The waxy cornstarch-containing enteric pellets dissolved at SIF in less than 10 minutes. Confocal images of film-coated pellets showed that waxy cornstarch-containing pellets had less drug dissolved than respective lactose-containing pellets. The observations were further confirmed by measurement of fluorescence intensity of riboflavin sodium phosphate in the film coat. The dissolution test was consistent with the confocal microscopy results. In conclusion, waxy cornstarch as a cofiller in the pellet cores minimizes premature drug diffusion from the core into the film coat layer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916953      PMCID: PMC2750318          DOI: 10.1208/pt030216

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  A method for quantifying differential expansion within hydrating hydrophilic matrixes by tracking embedded fluorescent microspheres.

Authors:  J Adler; A Jayan; C D Melia
Journal:  J Pharm Sci       Date:  1999-03       Impact factor: 3.534

2.  Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate.

Authors:  A Lamprecht; U F Schäfer; C Lehr
Journal:  Eur J Pharm Biopharm       Date:  2000-01       Impact factor: 5.571

3.  Waxy corn starch: a potent cofiller in pellets produced by extrusion-spheronization.

Authors:  R Junnila; P Palviainen; J Heinämäki; P Myllärinen; P Forssell; J Yliruusi
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

4.  Characterization of particle deformation during compression measured by confocal laser scanning microscopy.

Authors:  H X Guo; J Heinämäki; J Yliruusi
Journal:  Int J Pharm       Date:  1999-09-20       Impact factor: 5.875

5.  Thermal characterization of drug/polymer and excipient/polymer interactions in some film coating formulation.

Authors:  A O Okhamafe; P York
Journal:  J Pharm Pharmacol       Date:  1989-01       Impact factor: 3.765

  5 in total
  4 in total

1.  Development of enteric coated flurbiprofen tablets using Opadry/Acryl-Eze system--a technical note.

Authors:  Durriya Hashmat; M Harris Shoaib; Zafar Alam Mehmood; Rabia Bushra; Rabia Ismail Yousuf; Fahim Lakhani
Journal:  AAPS PharmSciTech       Date:  2008-01-18       Impact factor: 3.246

Review 2.  Challenges of Dissolution Methods Development for Soft Gelatin Capsules.

Authors:  Festo Damian; Mohammad Harati; Jeff Schwartzenhauer; Owen Van Cauwenberghe; Shawn D Wettig
Journal:  Pharmaceutics       Date:  2021-02-04       Impact factor: 6.321

3.  Exploration of cold extrusion for the preparation of enteric minitablets of isoniazid.

Authors:  M C Gohel; K G Sarvaiya
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

4.  Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from Lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies.

Authors:  Raymond R Tjandrawinata; Jessica Trisina; Puji Rahayu; Lorentius Agung Prasetya; Aang Hanafiah; Heni Rachmawati
Journal:  Drug Des Devel Ther       Date:  2014-09-25       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.